Hongbo Qin

Title: Innovations of Hongbo Qin in Antithrombotic Research

Introduction

Hongbo Qin is a notable inventor based in Kunming, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit coagulation factors. His work focuses on creating solutions for thrombotic diseases, which are critical in modern medicine.

Latest Patents

Hongbo Qin holds a patent for an "Oligosaccharide compound for inhibiting intrinsic coagulation factor X-enzyme complex, and preparation method therefor and uses thereof." This patent describes a purified oligosaccharide compound that exhibits antithrombotic activity. The invention includes a preparation method for the compound and its pharmaceutical applications as an intrinsic factor X-enzyme inhibitor. This innovation is essential for developing drugs aimed at preventing and treating thrombotic diseases.

Career Highlights

Throughout his career, Hongbo Qin has worked with various pharmaceutical companies, including Jiuzhitang Co., Ltd. and Mudanjiang Youbo Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to apply his research in practical settings, contributing to advancements in drug development.

Collaborations

Hongbo Qin has collaborated with notable colleagues, including Jikai Liu and Lutan Zhou. These partnerships have enhanced his research efforts and expanded the impact of his innovations in the pharmaceutical industry.

Conclusion

Hongbo Qin's work in developing antithrombotic compounds showcases his dedication to advancing medical science. His patent and collaborations reflect his significant role in addressing thrombotic diseases through innovative solutions.